Raised by an OB-GYN, Allara’s founder Rachel Blank had a broad understanding of women’s health. However, her own PCOS diagnosis at 21 exposed a gap in specialized care for hormonal conditions. This realization gave birth to Allara, a telehealth platform, devised for aiding women with hormonal diseases like PCOS, endometriosis, and hypothyroidism.
Despite having the advantage of prime healthcare, Blank found most OB-GYNs were not equipped to handle hormonal conditions. Driven by the lack of definitive care, she formed Allara, a platform where women can get consolidated treatment for hormonal disorders.
Proving instrumental for young women, Allara’s success is demonstrated by its 4X revenue growth in 2024 and the recent $26 million Series B funding secured from Index Ventures and GV. This follows a Series A funding of $10 million raised just 14 months ago.
Initially operating as a subscription service, Allara has forged partnerships with major health insurance providers over the past year. Companies like Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare now cover Allara’s services in 10 states. The latest funding enables Allara to push its insurance coverage across the US.
Allara’s holistic care model benefits not only patients. The remote-working facility it offers to healthcare professionals has been highly appreciated.
While other startup platforms also provide hormone condition treatment, they mainly focus on infertility or menopause. Allara, on the other hand, helps women manage chronic conditions even before they plan for a family. It’s this aspect that drew the interest of Index partner Martin Mignot, who expects patients to grow and evolve their healthcare needs with Allara. Reproductive and menopausal services may follow in the line of extensions.
Original source: Read the full article on TechCrunch
